Evaluation of out-of-pocket costs and treatment intensification with an SGLT2 inhibitor or GLP-1 RA in patients with type 2 diabetes and cardiovascular disease
Importance The latest guidelines continue to recommend sodium-glucose cotransporter 2
(SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for patients …
(SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for patients …
Pharmaceutical purchasing: a review of the landscape and implications for antidotal therapies
A Troger, MM Burns - Journal of Medical Toxicology, 2023 - Springer
The management of the poisoned patient often requires the utilization of uncommonly used
pharmaceutical interventions. These interventions can be associated with significant costs to …
pharmaceutical interventions. These interventions can be associated with significant costs to …
[HTML][HTML] Simulated Medicare drug price negotiation under the Inflation Reduction Act of 2022
Importance The Inflation Reduction Act of 2022 gives Medicare the authority to negotiate
prices for certain prescription drugs. Which drugs will be selected and how prices will be …
prices for certain prescription drugs. Which drugs will be selected and how prices will be …
Rape-related pregnancies in the 14 US states with total abortion bans
SL Dickman, K White, DU Himmelstein… - JAMA internal …, 2024 - jamanetwork.com
Methods| Because to our knowledge no recent reliable statelevel data on completed vaginal
rapes (forced and/or drug/alcohol–facilitated vaginal penetration) are available, we …
rapes (forced and/or drug/alcohol–facilitated vaginal penetration) are available, we …
Drugs likely subject to Medicare negotiation, 2026-2028
S Dickson, I Hernandez - Journal of Managed Care & Specialty Pharmacy, 2023 - jmcp.org
BACKGROUND: After the passage of the Inflation Reduction Act, Medicare will be able to
negotiate drug prices starting in 2026. The Congressional Budget Office has estimated the …
negotiate drug prices starting in 2026. The Congressional Budget Office has estimated the …
Stakeholder Perspectives of the Inflation Reduction Act's (2022) impact on prescription drugs: a narrative review
C Lieneck, M McLauchlan, V Adachi, R Billings - Pharmacy, 2023 - mdpi.com
In this review, we examine the impact of the Inflation Reduction Act (IRA) of 2022 on
pharmaceutical drugs in the United States, drawing on a diverse range of sources to …
pharmaceutical drugs in the United States, drawing on a diverse range of sources to …
Use of efficiency frontiers to align prices and clinical benefits of biologic therapies for plaque psoriasis
Importance The US lacks a systematic approach for aligning drug prices with clinical benefit,
and traditional cost-effectiveness analysis (CEA) faces political obstacles. The efficiency …
and traditional cost-effectiveness analysis (CEA) faces political obstacles. The efficiency …
The cancer premium–explaining differences in prices for cancer vs non-cancer drugs with efficacy and epidemiological endpoints in the US, Germany, and …
M Serra-Burriel, G Perényi, Y Laube, AP Mitchell… - …, 2023 - thelancet.com
Background High treatment prices of new cancer drugs are a global public health challenge
to patients and healthcare systems. Policymakers in the US and Europe are debating …
to patients and healthcare systems. Policymakers in the US and Europe are debating …
Inflation Reduction Act and US drug pricing
A Sarpatwari - bmj, 2022 - bmj.com
The Inflation Reduction Act, which President Biden signed into US law on 16 August 2022,
contains bold measures to tackle climate change and reduce prescription drug costs. 1 The …
contains bold measures to tackle climate change and reduce prescription drug costs. 1 The …
Medication cost concerns and disparities in patient-reported outcomes among a multiethnic cohort of patients with systemic lupus erythematosus
A Aguirre, K DeQuattro, S Shiboski, P Katz… - The Journal of …, 2023 - jrheum.org
Objective Concerns about the affordability of medications are common in systemic lupus
erythematosus (SLE), but the relationship between medication cost concerns and health …
erythematosus (SLE), but the relationship between medication cost concerns and health …